Literature DB >> 27068513

EEG Findings May Serve as a Potential Biomarker for Anti-NMDA Receptor Encephalitis.

Erin Pennock Foff1, David Taplinger2, Joanna Suski3, M Beatriz S Lopes4, Mark Quigg2.   

Abstract

Objective To determine if an electroencephalographic (EEG) characteristic, beta:delta power ratio (BDPR), is significantly higher for N-methyl-d-aspartate receptor encephalitis (NMDARE) patients than for non-NMDARE patients on presenting EEG. Identification of an additional EEG biomarker with significant specificity for NMDARE (in the absence of frank delta brush) could potentially allow for early identification of at-risk patients. Methods Single center retrospective comparison of NMDARE and non-NMDARE consecutive cases of encephalitis, collated over a 6-year period (from 2008 to 2014). Results None of the 10 NMDARE patients displayed the extreme delta brush pattern on EEG previously described, but the ratio of BDPR was significantly higher for NMDARE patients (P < .005). There was no significant relationship between BDPR and the time of recording from symptom onset. Additional analysis of clinical characteristics also indicated that the patients with NMDARE (median age 19.5 years) were younger than the 5 patients with non-NMDARE (median age 36 years). Encephalopathy, seizure, and psychiatric complaints were the most common diagnoses at time of first health care presentation and did not favor a single etiology, though the latter was present only in the NMDARE population (50% at T0). Prodromal illness featuring headache was more common in the non-NMDARE population. Outcomes, as measured by the Modified Rankin Scale, were globally better in the NMDARE group. Conclusions Patients with NMDARE had a significantly higher BDPR on EEG when compared with non-NMDARE patients even in the absence of extreme delta brush. This suggests that early EEG characteristics may be helpful in distinguishing NMDARE from non-NMDARE. © EEG and Clinical Neuroscience Society (ECNS) 2016.

Entities:  

Keywords:  anti–NMDA receptor encephalitis; encephalitis; encephalopathy

Mesh:

Year:  2016        PMID: 27068513     DOI: 10.1177/1550059416642660

Source DB:  PubMed          Journal:  Clin EEG Neurosci        ISSN: 1550-0594            Impact factor:   1.843


  11 in total

1.  Clinical characteristics and outcomes between children and adults with anti-N-Methyl-D-Aspartate receptor encephalitis.

Authors:  Qi Huang; Yuan Wu; Rongfa Qin; Xing Wei; Meigang Ma
Journal:  J Neurol       Date:  2016-09-15       Impact factor: 4.849

2.  Altered cerebral blood flow in patients with anti-NMDAR encephalitis.

Authors:  Ailiang Miao; Qianqian Liu; Zonghong Li; Wen Liu; Lingling Wang; Jianqing Ge; Chuanyong Yu; Yingxin Wang; Shuyang Huang; Yuanwen Yu; Qi Shi; Jintao Sun; Xiaoshan Wang
Journal:  J Neurol       Date:  2020-03-04       Impact factor: 4.849

3.  Spectrum and Evolution of EEG Changes in Anti-NMDAR Encephalitis.

Authors:  Lakshminarayanapuram Gopal Viswanathan; Shreedhara A Siddappa; Madhu Nagappa; Anita Mahadevan; Shishir Duble; Parayil S Bindu; Arun B Taly; Sanjib Sinha
Journal:  Ann Indian Acad Neurol       Date:  2020-11-06       Impact factor: 1.383

4.  A Case of HIV Seroconversion Presenting Similarly to Anti-N-methyl-D-aspartate Receptor Encephalitis.

Authors:  Heather VanDongen-Trimmer; Kumar Sannagowdara; Binod Balakrishnan; Raquel Farias-Moeller
Journal:  Neurocrit Care       Date:  2019-10       Impact factor: 3.532

5.  Unilateral predominance of abnormal movements: A characteristic feature of the pediatric anti-NMDA receptor encephalitis?

Authors:  Vanessa Benjumea-Cuartas; Monika Eisermann; Hina Simonnet; Marie Hully; Rima Nabbout; Isabelle Desguerre; Anna Kaminska
Journal:  Epilepsy Behav Case Rep       Date:  2017-01-18

6.  Influencing electroclinical features and prognostic factors in patients with anti-NMDAR encephalitis: a cohort follow-up study in Chinese patients.

Authors:  Yingxin Wang; Ailiang Miao; Yongwei Shi; Yihan Li; Jianqing Ge; Lingling Wang; Chuanyong Yu; Haiyan Xu; Yuanwen Yu; Shuyang Huang; Xiaoshan Wang
Journal:  Sci Rep       Date:  2020-07-01       Impact factor: 4.379

Review 7.  Current Progress on Assessing the Prognosis for Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis.

Authors:  Hao Wang; Zheng Xiao
Journal:  Biomed Res Int       Date:  2020-04-14       Impact factor: 3.411

8.  Using EEG and MEG to characterize extreme delta brush in a patient with anti-NMDA receptor encephalitis.

Authors:  Ailiang Miao; Yongwei Shi; Jing Xiang; Xiaoshan Wang; Jianqing Ge; Qiqi Chen; Yuanwen Yu; Chuanyong Yu; Di Wu
Journal:  BMC Neurol       Date:  2021-03-22       Impact factor: 2.474

Review 9.  Current Status of Biomarkers in Anti-N-Methyl-D-Aspartate Receptor Encephalitis.

Authors:  Nicolás Lundahl Ciano-Petersen; Pablo Cabezudo-García; Sergio Muñiz-Castrillo; Jérôme Honnorat; Pedro Jesús Serrano-Castro; Begoña Oliver-Martos
Journal:  Int J Mol Sci       Date:  2021-12-04       Impact factor: 5.923

10.  Features and Prognostic Value of Quantitative Electroencephalogram Changes in Critically Ill and Non-critically Ill Anti-NMDAR Encephalitis Patients: A Pilot Study.

Authors:  Nan Jiang; Hongzhi Guan; Qiang Lu; Haitao Ren; Bin Peng
Journal:  Front Neurol       Date:  2018-10-05       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.